CytRx Corporation (NASDAQ:CYTR) is amongst the top gainer in the early few hours. The stock has surged 10.43% and is trading at $1.27 with an unusual massive volume of 3.93 million shares. The stock has a 52-week range of $0.24-$1.72. CytRx Corporation (CytRx) is a biopharmaceutical research and development company engaged in the development of human therapeutics. The Company’s drug development pipeline includes two product candidates in clinical development for cancer indications, including registration studies of tamibarotene for the treatment of acute promyelocytic leukemia (APL).
Subscribe to daily free stock newsletter on top stocks by visiting : http://www.pennystockpickreport.com/
Genzyme Corporation (NASDAQ:GENZ) is amongst the top gainer in the early few hours. The stock has spurted 5.01% and is trading at $53.69 with a massive volume of 3.43 million shares. The stock has a 52-week range of $47.09-$73.75. Genzyme Corporation (Genzyme) is a biotechnology company. Genzyme operates in four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases and other chronic debilitating diseases, including a family of diseases known as lysosomal storage disorders (LSDs).
Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) climbed up 15.28% over its previous day’s price and now trades at $7.46 on an unusual massive volume of 2.52 million shares The stock today also touched a new 52 week high at $7.78. The company announced that The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring. PureGraft is able to prepare both small and large volumes of fat grafting tissue ranging from 50 mL to 250 mL. Puregraft maintains sterility while optimizing the yield of tissue to be grafted, which provides significant utility to physicians.
About http://www.pennystockpickreport.com/
Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap stocks, Biotech Stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.
